Wikidata:Database reports/Constraint violations/P3358

• Summary
• List of properties
• Property proposal
• Popular properties
• Special:ConstraintReport

Constraint violations report for positive prognostic predictor for (Discussion, uses, items, changes, related properties): the presence of the genetic variant helps to prognose good outcome for the disease
Data time stamp: 16 February 2024, 11:02 (UTC) — Items processed: 70
The report is generated based on the settings on Property:P3358#P2302.
Updates overwrite this page. Some may already be fixed since the last update: check RecentChangesLinked.
When incremental dumps and the bot work as planned, items fixed before 07:00 UTC disappear in the next update. The report is not updated if only the item count changes.
The report can include false positives. There is no need to "fix" them.

"Scope" violations

Violations count: 0

"Value type disease (Q12136)" violations

Violations count: 0

Types statistics

Accepted	Type	Usage
Yes	disease (Q12136)	71
Yes	acute leukemia (Q976388)	15
Yes	myeloid leukemia (Q11688946)	14
Yes	large intestine cancer (Q12048781)	9
Yes	colorectal neoplasm (Q58833976)	9
Yes	breast disease (Q4959796)	8
Yes	breast neoplasm (Q23929670)	8
Yes	rare disease (Q929833)	8
Yes	thoracic cancer (Q18556617)	8
Yes	carcinoma (Q33525)	7
Yes	lung cancer (Q47912)	7
Yes	glioma (Q1365309)	6
Yes	squamous cell carcinoma (Q681817)	5
Yes	astrocytoma (Q177755)	5
Yes	ovarian neoplasm (Q11793790)	5
Yes	adenocarcinoma (Q356033)	4
Yes	head and neck disease (Q55789477)	4
Yes	lung carcinoma (Q18556110)	4
Yes	endocrine gland cancer (Q18554878)	4
Yes	inherited gynecological tumor (Q55785864)	3
Yes	connective tissue neoplasm (Q3542012)	3
Yes	cerebrum cancer (Q18556019)	3
Yes	central nervous system cancer (Q18556002)	3
Yes	gastrointestinal system cancer (Q5526839)	3
Yes	rare genetic endocrine disease (Q55785525)	3
Yes	head and neck carcinoma (Q18554836)	3
Yes	female reproductive organ cancer (Q18554220)	3
Yes	lymphoblastic leukemia (Q18553852)	3
Yes	ovarian disease (Q7113244)	3
Yes	head and neck cancer (Q1783924)	3
Yes	bone sarcoma (Q56014469)	3
Yes	low grade glioma (Q55789758)	2
Yes	skin cancer (Q192102)	2
Yes	lymphoma (Q208414)	2
Yes	renal cell carcinoma (Q1164529)	2
Yes	leukemia (Q29496)	2
Yes	brain cancer (Q9303627)	2
Yes	small lymphocytic lymphoma (Q9022766)	2
Yes	stomach neoplasm (Q4335552)	2
Yes	cancer (Q12078)	2
Yes	cartilage tumor (Q5047353)	2
Yes	bladder cancer (Q504775)	2
Yes	neoplastic syndrome (Q55789476)	2
Yes	childhood cancer (Q5097977)	2
Yes	chronic leukemia (Q5113979)	2
Yes	rare genetic immune disease (Q55785867)	2
Yes	acquired aplastic anemia (Q55785593)	2
Yes	melanoma (Q180614)	2
Yes	ocular melanoma (Q18554893)	2
Yes	myeloid neoplasm (Q18553734)	2
Yes	uveal cancer (Q18555949)	2
Yes	connective tissue benign neoplasm (Q18553680)	2
Yes	cell type cancer (Q18553402)	2
Yes	clear cell carcinoma (Q18556242)	2
Yes	stomach disease (Q175827)	2
Yes	precursor B lymphoblastic lymphoma/leukemia (Q18557465)	2
Yes	ovarian cancer (Q172341)	2
Yes	myeloproliferative disorders (Q1898104)	2
Yes	fibromatosis (Q1410851)	2
Yes	pancreas disease (Q7130407)	1
Yes	pancreatic neoplasm (Q7130412)	1
Yes	autonomic nervous system neoplasm (Q18555138)	1
Yes	serous carcinoma (Q7455058)	1
Yes	mature T-cell and NK-cell lymphoma (Q18553445)	1
Yes	neoplasm of oropharynx (Q55789594)	1
Yes	tumor (Q133212)	1
Yes	esophageal carcinoma (Q18553999)	1
Yes	disease of cellular proliferation (Q18554796)	1
Yes	neoplasm (Q1216998)	1
Yes	renal carcinoma (Q18556333)	1
Yes	rhabdomyosarcoma (Q1898141)	1
Yes	pharyngeal cancer (Q2085187)	1
Yes	sarcoma (Q223911)	1
Yes	transitional cell carcinoma (Q2501186)	1
Yes	neuroblastic tumor (Q18975102)	1
Yes	stomach cancer (Q189588)	1
Yes	liver carcinoma (Q18557387)	1
Yes	non-small-cell lung carcinoma (Q3658562)	1
Yes	bone cancer (Q18554919)	1
Yes	B-cell lymphoma (Q4833719)	1
Yes	pancreatic adenocarcinoma (Q18556189)	1
Yes	bladder carcinoma (Q18556149)	1
Yes	ovarian carcinoma (Q18556145)	1
Yes	synovium cancer (Q18555170)	1
Yes	Ewing family of tumor (Q5419064)	1
Yes	ovarian serous tumor (Q19000698)	1
Yes	malignant ovarian surface epithelial-stromal neoplasm (Q18555014)	1

"Entity types" violations

Violations count: 0

"Type sequence variant (Q15304597)" violations

Violations count: 8

• FLT3 TKD MUTATION (Q28381821): Nonsynonymous Variant (Q27905684)
• ABCB1 I1145I (Q28421333): Synonymous Variant (Q28419125)
• MDM2 RS34886328 (Q28423328): 3 Prime UTR Truncation (Q28419139)
• FGFR1 Amplification (Q28444992): Transcript Amplification (Q27907091)
• GNAS c.393T>C (Q29938321): Synonymous Variant (Q28419125)
• PIK3CA EXON 20 MUTATION (Q56241010):
• MYB AMPLIFICATION (Q86217009):
• PIK3CA Rare Mutation (Q102214202):

Types statistics

Accepted	Type	Usage
Yes	sequence variant (Q15304597)	19
Yes	missense mutation (Q2656896)	12
Yes	transcript fusion (Q28419128)	8
Yes	Protein Altering Variant (Q27907087)	7
Yes	Loss Of Function Variant (Q27907094)	7
Yes	transcript variant (Q28371782)	5
Yes	gene variant (Q28381983)	4
Yes	exon variant (Q27908063)	3
Yes	Gain Of Function Variant (Q28371786)	2
No	Synonymous Variant (Q28419125)	2
No	Nonsynonymous Variant (Q27905684)	1
No	Transcript Amplification (Q27907091)	1
Yes	inframe variant (Q28419132)	1
Yes	Polymorphic Sequence Variant (Q28419136)	1
No	3 Prime UTR Truncation (Q28419139)	1